Total Payments
$5,667
2024 Payments
$1,141
Companies
35
Transactions
266
Medicare Patients
16,335
Medicare Billing
$600,430
Payment Breakdown by Category
Food & Beverage$5,667 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,667 | 266 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $852.29 | 36 | $0 (2024) |
| Abbott Laboratories | $761.74 | 22 | $0 (2024) |
| PFIZER INC. | $714.64 | 35 | $0 (2024) |
| Amgen Inc. | $443.09 | 23 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $387.05 | 22 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $342.69 | 19 | $0 (2024) |
| Merck Sharp & Dohme LLC | $308.48 | 17 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $290.61 | 13 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $274.51 | 13 | $0 (2024) |
| Boston Scientific Corporation | $219.82 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,141 | 51 | Novartis Pharmaceuticals Corporation ($253.35) |
| 2023 | $1,110 | 56 | PFIZER INC. ($249.26) |
| 2022 | $1,168 | 61 | PFIZER INC. ($169.03) |
| 2021 | $780.31 | 34 | Abbott Laboratories ($194.57) |
| 2020 | $127.54 | 7 | Abbott Laboratories ($47.43) |
| 2019 | $649.90 | 22 | Abbott Laboratories ($223.24) |
| 2018 | $504.04 | 24 | Abbott Laboratories ($142.05) |
| 2017 | $185.82 | 11 | Janssen Pharmaceuticals, Inc ($34.92) |
All Payment Transactions
266 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/15/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $28.58 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/15/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/14/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/13/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $32.24 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/17/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.47 | General |
| Category: Cardiovascular | ||||||
| 10/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: DIABETES | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/27/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/17/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $28.11 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Cardiology | ||||||
| 08/27/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/16/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/13/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $24.39 | General |
| 08/06/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $26.58 | General |
| Category: Cardiovascular Device | ||||||
| 07/24/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Cardiology | ||||||
| 07/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $26.03 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/23/2024 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: Vascular | ||||||
| 07/12/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Cardiology | ||||||
| 06/07/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/05/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 4,291 | 4,878 | $462,601 | $144,523 |
| 2022 | 23 | 4,724 | 5,435 | $474,725 | $150,265 |
| 2021 | 23 | 4,024 | 4,510 | $454,966 | $151,785 |
| 2020 | 32 | 3,296 | 3,613 | $467,818 | $153,856 |
Total Patients
16,335
Total Services
18,436
Medicare Billing
$600,430
Procedure Codes
102
All Medicare Procedures & Services
102 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 471 | 546 | $114,114 | $45,123 | 39.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 655 | 668 | $109,552 | $32,251 | 29.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 1,747 | 2,207 | $57,382 | $12,052 | 21.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 99 | 99 | $31,383 | $10,530 | 33.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 134 | 134 | $25,862 | $6,649 | 25.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 78 | 105 | $16,905 | $6,298 | 37.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2023 | 235 | 236 | $21,004 | $6,193 | 29.5% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 27 | 27 | $19,880 | $5,587 | 28.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 54 | 54 | $16,524 | $5,255 | 31.8% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Facility | 2023 | 159 | 163 | $8,150 | $2,438 | 29.9% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Facility | 2023 | 80 | 85 | $6,545 | $1,987 | 30.4% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 109 | 109 | $5,450 | $1,510 | 27.7% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 158 | 158 | $5,214 | $1,459 | 28.0% |
| 93925 | Ultrasound of leg arteries or artery grafts | Facility | 2023 | 50 | 50 | $4,400 | $1,297 | 29.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 12 | $3,372 | $1,225 | 36.3% |
| 93975 | Complete ultrasound of abdomen and pelvis artery and vein blood flow | Facility | 2023 | 20 | 20 | $2,580 | $814.53 | 31.6% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Facility | 2023 | 15 | 15 | $2,865 | $790.20 | 27.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 11 | $1,562 | $751.85 | 48.1% |
| 93979 | Ultrasound of aorta, vena cava, groin vessels or bypass grafts | Facility | 2023 | 40 | 40 | $2,200 | $553.04 | 25.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 62 | 62 | $3,224 | $552.84 | 17.1% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Facility | 2023 | 27 | 29 | $1,711 | $397.32 | 23.2% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 20 | 20 | $1,160 | $326.23 | 28.1% |
| 93926 | Ultrasound of one leg arteries or artery grafts | Facility | 2023 | 17 | 17 | $935.00 | $294.41 | 31.5% |
| 93272 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | Facility | 2023 | 11 | 11 | $627.00 | $186.80 | 29.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 483 | 537 | $112,233 | $43,477 | 38.7% |
About Dr. John Ivanoff, M.D
Dr. John Ivanoff, M.D is a Interventional Cardiology healthcare provider based in Tulsa, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497725857.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Ivanoff, M.D has received a total of $5,667 in payments from pharmaceutical and medical device companies, with $1,141 received in 2024. These payments were reported across 266 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($5,667).
As a Medicare-enrolled provider, Ivanoff has provided services to 16,335 Medicare beneficiaries, totaling 18,436 services with total Medicare billing of $600,430. Data is available for 4 years (2020–2023), covering 102 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Location Tulsa, OK
- Active Since 01/26/2006
- Last Updated 06/13/2019
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1497725857
Products in Payments
- ELIQUIS (Drug) $767.67
- ENTRESTO (Drug) $543.06
- XARELTO (Drug) $387.05
- LEQVIO (Drug) $309.23
- VERQUVO (Drug) $308.48
- JARDIANCE (Drug) $290.61
- Repatha (Biological) $288.31
- Assurity Pacemaker (Device) $270.04
- FARXIGA (Drug) $201.62
- LifeVest (Device) $189.89
- NEXLETOL (Drug) $162.94
- PRALUENT (Drug) $159.38
- Corlanor (Drug) $154.78
- HeartMate 3 Left Ventricular Assist Device (Device) $136.56
- General - Therapies (Device) $121.52
- MULTAQ (Drug) $115.13
- Confirm Rx (Device) $109.94
- BRILINTA (Drug) $75.08
- MITRACLIP (Device) $71.37
- Pacemakers (Device) $62.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Tulsa
Kamran Muhammad, Md, MD
Interventional Cardiology — Payments: $1.2M
Interventional Cardiology $1.2M
Stewart Katz, Md, MD
Interventional Cardiology — Payments: $34,334
Interventional Cardiology $34,334
Dr. Tucker Harrison, Do, DO
Interventional Cardiology — Payments: $20,475
Interventional Cardiology $20,475
Andrew Kurklinsky, Md, MD
Interventional Cardiology — Payments: $20,103
Interventional Cardiology $20,103
Dr. Ralph Ensley, M.d, M.D
Interventional Cardiology — Payments: $12,516
Interventional Cardiology $12,516
Dr. Robert Smith, M.d, M.D
Interventional Cardiology — Payments: $10,579
Interventional Cardiology $10,579